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Arthropod-borne viruses (arboviruses) pose a considerable threat to human and animal health, yet
effective control measures have proven difficult to implement, and novel means of controlling their
replication in arthropod vectors, such as mosquitoes, are urgently required. One of the most
exciting approaches to emerge from research on arthropods is the use of the endosymbiotic
intracellular bacterium Wolbachia to control arbovirus transmission from mosquito to vertebrate.
These a-proteobacteria propagate through insects, in part through modulation of host
reproduction, thus ensuring spread through species and maintenance in nature. Since it was
discovered that Wolbachia endosymbiosis inhibits insect virus replication in Drosophila species,
these bacteria have also been shown to inhibit arbovirus replication and spread in mosquitoes.
Importantly, it is not clear how these antiviral effects are mediated. This review will summarize
recent work and discuss determinants of antiviral effectiveness that may differ between individual
Wolbachia/vector/arbovirus interactions. We will also discuss the application of this approach to
field settings and the associated risks.
Introduction
Arthropod-borne viruses (arboviruses) are transmitted in
nature between susceptible vertebrate hosts and blood-
feeding arthropod vectors, such as mosquitoes, sandflies,
midges and ticks. Upon infection with arboviruses, verte-
brate hosts can develop a range of symptoms from mild
to severe, including encephalitis and haemorrhagic fever.
Arthropod vectors acquire a lifelong, generally asympto-
matic infection through feeding on viraemic vertebrates.
Following the initial replication in midgut or hindgut
epithelial cells, virus is released into the haemocoel from
where it disseminates to other tissues, most importantly
the salivary glands and ducts. The transmission cycle is
completed when arboviruses present in the arthropod’s
saliva are passed to a vertebrate host during a subsequent
bloodmeal. Arbovirus distribution is dependent on the
presence of vector species in a given area. Changes in climate
and vector distribution, and an increase in urbanization,
human travel and livestock movements, can all potentially
impact on arbovirus transmission (Weaver & Reisen, 2010).
Most arboviruses are grouped into four RNA virus families,
and include the positive strand Togaviridae and Flaviviridae,
the negative strand segmented Bunyaviridae and the dsRNA
segmented Reoviridae (Weaver & Reisen, 2010).
Control of arboviral disease may be achieved by a number
of measures, such as vaccination or the development
of antiviral drugs; however, these are often not available
and/or prove difficult to develop. For example, there is no
effective vaccine for dengue virus (DENV; Flaviviridae),
which impacts significantly on human health worldwide
(Halstead, 2012) or emerging arboviruses, such as the alp-
havirus chikungunya (CHIKV; Togaviridae).
Indeed, preventing transmission from arthropod vector
to vertebrate, and thus preventing infection altogether,
may present a valuable alternative in combating arboviral
disease. Vector eradication programmes form part of
such strategies. In the past, sterile mosquitoes have been
released, and more recently, genetic modification tech-
niques have been used successfully to control mosquito
populations (Alphey et al., 2013; Black et al., 2011; Lacroix
et al., 2012; Wilke & Marrelli, 2012). However, because one
approach alone is unlikely to be sufficient and/or always
applicable, novel strategies that work at the level of vector
control are required.
In this context, current efforts to manipulate transmission
of arboviruses by mosquitoes through the use of the bac-
terium Wolbachia merit greater attention. As RNA virus
replication is inhibited by these endosymbionts in the
model arthropod Drosophila melanogaster (Hedges et al.,
2008; Teixeira et al., 2008),Wolbachia has also been used to
control arbovirus replication in mosquitoes and their
transmission to vertebrates.
Here we summarize recent research focusing onWolbachia/
mosquito/arbovirus interactions and discuss progress into
the mechanisms by which these endosymbionts confer
antiviral resistance to their hosts, as well as perspectives for
further research.
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Wolbachia and reproductive phenotypes
Wolbachia is a genus of intracellular a-proteobacteria (family
Rickettsiaceae), which is thought to infect 40–75% of all
arthropod species and several nematodes (Hilgenboecker
et al., 2008; Zug & Hammerstein, 2012). First discovered in
the mosquito Culex pipiens (Hertig & Wolbach, 1924), these
bacteria have now been found in a number of vectormosquito
species, although not the major arbovirus vector Aedes aegypti
(Kittayapong et al., 2000; Sinkins, 2004).
Wolbachia has been extensively studied because of its
ability to significantly alter the biology of the host in the
symbiotic relationship. These alterations are thought to
dramatically increase the spread of the bacteria through
insect populations and include male killing, parthenogen-
esis, feminization and cytoplasmic incompatibility (CI)
(Werren et al., 2008). In mosquito populations, Wolbachia
is spread and maintained through unidirectional and bi-
directional CI (Kambhampati et al., 1993; Sinkins, 2004;
Yen & Barr, 1973), and our understanding of this process
is vital to successful introduction of Wolbachia-infected
mosquitoes into wild populations (as discussed in the final
section of this review). The process of CI is explained below
and summarized in Fig. 1.
Alterations in spermatogenesis during male development
result in the failure of Wolbachia-infected males to pro-
duce offspring when mating with either uninfected females
(unidirectional CI) or females infected with a different
strain of Wolbachia (bidirectional CI) (Fig. 1). The altered
sperm results in late entry of the male pronucleus into
mitosis. Thus, the parental chromosomes fail to align
properly and haploid embryos are produced. The presence
of compatible Wolbachia in fertilized eggs, through vertical
transmission, rescues CI (Landmann et al., 2009; Stoutha-
mer et al., 1999; Tram et al., 2006; Tram & Sullivan, 2002).
Importantly, females infected with Wolbachia can mate
successfully with uninfected males, giving them an evolu-
tionary advantage over uninfected females, as they produce
viable offspring with both infected and uninfected males
(Turelli & Hoffmann, 1991, 1995; Yen & Barr, 1971).
As early as the 1960s, mosquitoes that exhibited CI were
considered a viable option for the control of disease vectors.
One study reported the large scale release of Wolbachia-
infected C. pipiens into wild populations in order to elimi-
nate this population from a large urban area (Laven, 1967).
More recently, a virulent strain ofWolbachia found in labo-
ratory strains of D. melanogaster, wMelPop, was cited as a
possible mechanism for the control of mosquito popula-
tions and consequently the spread of arboviruses through
transinfection (see below) (Brownstein et al., 2003; Yeap
et al., 2011). This particular strain of Wolbachia is known
to infect Drosophila at a high density and reduce lifespan.
It has since been shown that it is possible to transinfect
Aedes albopictus and Ae. aegypti populations with wMelPop
and other Wolbachia strains, and for them to be stably
maintained in populations (Blagrove et al., 2013; McMeni-
man et al., 2009; Xi et al., 2005). The potential ofWolbachia
to control arbovirus spread, however, was not fully realized
until 2008 when two groups reported that Wolbachia
infection in D. melanogaster led to increased protection
against insect RNA viruses, suggesting that Wolbachia was
able to control viral replication in infected flies (Hedges
Bidirectional Cl
No offspring
No offspring No offspring
Infected by Wolbachia strain 1
Infected by Wolbachia strain 2
Non-infected
Unidirectional Cl
Fig. 1. CI induced by Wolbachia infection. CI is presented in two forms in insects. (a) The process by which bidirectional CI
takes place. Here, males and females infected with two different strains ofWolbachia are unable to produce viable offspring. (b)
The process of unidirectional CI, where infected females are able to successfully mate with both uninfected males and males
infected with the same strain of Wolbachia.
S. M. Rainey and others
518 Journal of General Virology 95
et al., 2008; Teixeira et al., 2008). The remainder of this
review will discuss this in more detail.
Wolbachia and antiviral activity in insects
Studies in the model Drosophila
Initial studies carried out in D. melanogaster concluded
that the Wolbachia strains wMelCS and wMelPop increased
fly longevity upon infection with the RNA viruses Dro-
sophila C virus (DCV; Dicistroviridae), Flock House virus
(FHV; Nodaviridae) and cricket paralysis virus (CrPV;
Dicistroviridae), but not the DNA virus insect iridescent
virus 6 (IIV-6; Iridoviridae) (Hedges et al., 2008; Teixeira
et al., 2008). Moreover, viral titres were significantly
reduced in the presence of Wolbachia in the case of DCV
and nora virus (NoraV; a potentially novel family within
the Picornavirales).
Further studies in Drosophila simulans, which are naturally
infected with multiple Wolbachia strains, showed that only
those Wolbachia strains that are present in high densities
(wMel, wRi and wAu), conferred antiviral resistance to
DCV and FHV. In DCV-infected D. simulans, Wolbachia-
mediated protection did not directly correlate with reduced
viral copy numbers (Osborne et al., 2009). For example,
wRi significantly increased lifespan upon infection with
DCV compared to controls; however, there was no signi-
ficant decrease in virus accumulation. Conversely, Teixeira
et al. (2008) and Hedges et al. (2008) showed that DCV
titres in D. melanogaster were strongly reduced by Wolba-
chia infection (Hedges et al., 2008; Teixeira et al., 2008).
During FHV infection, virus titre was unaffected but virus-
induced pathology was decreased, resulting in increased life
spans of infected flies (Teixeira et al., 2008). A recent study
also demonstrated that replication of the dsRNA virus
bluetongue virus (BTV; Reoviridae) in D. melanogaster is
inhibited in the presence of Wolbachia (Shaw et al., 2012).
Taken together these data suggest that reduction of viral
titres is not the only mechanism responsible forWolbachia-
mediated protection. These findings in the model organism
Drosophila have led to considerable interest in the field of
human-pathogenic mosquito-borne viruses. The key find-
ings are summarized in Table 1.
Mosquitoes and Wolbachia-mediated antiviral activity
Aedes and Culex species are the major arthropod vectors
for DENV, West Nile virus (WNV) and yellow fever virus
(YFV) (all Flaviviridae), as well as CHIKV (Togaviridae)
(Weaver & Reisen, 2010). Among the major arbovirus
Table 1. Antiviral effects of Wolbachia in different Drosophila/virus associations
Species Wolbachia
strain
Nature of
host-Wolbachia
association
Virus Antiviral effect
exerted by Wolbachia
Reference
Drosophila
melanogaster
wMelCS Natural DCV Increased lifespan of infected flies;
reduced virus proliferation
(Teixeira et al., 2008)
FHV* Increased lifespan of infected flies;
no effect of virus replication
NoraV Reduced virus proliferation
IIV-6 Decreased lifespan of infected flies;
increased virus proliferation
DCV, FHV*,
CrPV
Increased lifespan of infected flies;
reduced virus proliferation
(Hedges et al., 2008)
wMelPop Laboratory strain DCV, FHV*,
CrPV
Increased lifespan of infected flies;
reduced virus proliferation
(Hedges et al., 2008)
wMel Natural CHIKV*, LACV* No effect (Glaser & Meola, 2010)
WNV* Reduced virus proliferation (Glaser & Meola, 2010)
BTV* Reduced virus proliferation (Shaw et al., 2012)
Drosophila
simulans
wMel Transinfection DCV Increased lifespan of infected flies;
reduced virus proliferation
(Osborne et al., 2009)
wAu Natural DCV Increased lifespan of infected flies;
reduced virus proliferation
(Osborne et al., 2009)
FHV* Increased lifespan of infected flies; (Osborne et al., 2009)
wRi Natural DCV Increased lifespan of infected flies (Osborne et al., 2009)
FHV* Increased lifespan of infected flies (Osborne et al., 2009)
wHa Natural DCV, FHV* No effect (Osborne et al., 2009)
wNo Natural DCV, FHV* No effect (Osborne et al., 2009)
BTV, Bluetongue virus; CHIKV, chikungunya virus; CrPV, cricket paralysis virus; DCV, Drosophila C virus; FHV, Flock House virus; IIV-6, insect
iridescent virus 6; LACV, La Crosse virus; NoraV, nora virus; WNV, West Nile virus.
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vectors, Ae. albopictus, Aedes bromeliae and members of the
C. pipiens complex are naturally infected with Wolbachia
endosymbionts (Ae. albopictus harbours wAlbA and wAlbB,
and C. pipiens wPip) (Armbruster et al., 2003; Hertig &
Wolbach, 1924; Kittayapong et al., 2000; Osei-Poku et al.,
2012; Sinkins et al., 1995), whereas Ae. aegypti mosquitoes
lack this association (Table 2).
Unlike the above-mentioned native Drosophila/Wolbachia
interactions, the ability of homologous Wolbachia strains
to confer resistance in mosquitoes is limited by tissue
density and distribution. For example, wAlbA and wAlbB
did not inhibit DENV replication to significant levels in
Ae. albopictus mosquitoes (Bian et al., 2010), but reduced
viral infection of the salivary glands and thus may limit
transmission (Mousson et al., 2012). Furthermore, the
wAlbA and wAlbB infected Ae. albopictus cell line Aa23
showed decreased DENV titres compared to Wolbachia-
cured controls. Notably this cell line has a significantly
higher Wolbachia density than somatic tissues of Ae. albo-
pictus, which may explain its restrictive phenotype (Lu
et al., 2012). A study of the interaction between CHIKV
and wAlbA and wAlbB in Ae. albopictusmosquitoes showed
no decrease in viral titres in the presence of Wolbachia
compared to controls. Viral titres in Wolbachia-free mos-
quitoes were extremely variable compared to those har-
bouring Wolbachia, suggesting some level of interaction
(Mousson et al., 2010). Lastly, homologous wPip infections
in Culex quinquefasciatus resulted in reduced WNV titres
and transmission rates (Glaser & Meola, 2010). Given that
Wolbachia confers resistance to RNA viruses in Drosophila
(Hedges et al., 2008; Teixeira et al., 2008), and that Wolba-
chia strains can be stably introduced and maintained
in heterologous host mosquitoes (Blagrove et al., 2013;
McMeniman et al., 2009; Xi et al., 2005), multiple studies
have investigated whether Wolbachia transinfection into
different mosquito species would result in vectors refractory
to infection with important viral pathogens.
Transinfection and resulting phenotypes
Transinfection of mosquitoes with heterologous Wolbachia
strains is by no means trivial, as not all hosts are equally
permissive and Wolbachia strains differ in their ability to
stably transfect certain new host species (Werren et al.,
2008). Most likely as a consequence of evolutionary adap-
tation to their hosts, naturally occurring Wolbachia strains
differ in their genome organization and in the reproductive
phenotypes they cause (reviewed by Serbus et al., 2008;
Werren et al., 2008). In nature, Wolbachia cross-species
transmission events occur frequently (Haine et al., 2005;
Heath et al., 1999; Huigens et al., 2000, 2004; Kraaijeveld
et al., 2011; Vavre et al., 1999; Werren et al., 1995) and are
thought to result in a loss of infection or, if infection is
established, in a temporary increase in virulence, caused
either by competition for resources or by disproportional
host immune activation (Le Clec’h et al., 2012; Lipsitch
Table 2. Antiviral effect of Wolbachia in different mosquito/arbovirus associations
Mosquito host Wolbachia strain Nature of
host-Wolbachia
association
Virus Antiviral effect
exerted by Wolbachia
Reference
Aedes aegypti wAlbB Transinfection DENV Reduced virus proliferation Bian et al. (2010)
wMel Transinfection DENV Blockage of viral proliferation Walker et al. (2011)
WNV No effect Hussain et al. (2013)
CHIKV, Reduced virus proliferation van den Hurk et al. (2012)
YFV
wMelPop Transinfection DENV, CHIKV Reduced virus proliferation Moreira et al. (2009)
YFV Reduced virus proliferation van den Hurk et al. (2012)
WNV Reduced virus proliferation Hussain et al. (2013)
Aedes albopictus wAlbA and wAlbB Natural CHIKV No effect Mousson et al. (2010)
DENV No effect on virus replication
in midgut; reduced virus
dissemination and transmission
DENV No effect Lu et al. (2012)
wMel (wAlbA and
wAlbB present)
Transinfection CHIKV Reduced virus transmission Blagrove et al. (2013)
Aedes
polynesiensis
wPolA Natural DENV No effect Bian et al. (2013b)
wAlbB Transinfection DENV Reduced virus proliferation Bian et al. (2013b)
Culex
quinquefasciatus
wPip Natural WNV Reduced virus proliferation Glaser & Meola (2010)
Armigeres
subalbatus
Not subgrouped Natural JEV No effect in salivary gland cells Tsai et al. (2006)
CHIKV, Chikungunya virus; DENV, dengue virus; JEV, Japanese encephalitis virus; WNV, West Nile virus; YFV, yellow fever virus.
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& Moxon, 1997). In order to stably introduce the D.
melanogaster Wolbachia strain wMelPop into Ae. aegypti,
McMeniman et al. (2008) first had to pre-adapt wMelPop
to an Ae. albopictus-derived cell line by long-term serial
passage (McMeniman et al., 2008). After about 2.5 years in
culture the pre-adapted strain was transferred into Ae.
aegypti and Anopheles gambiae cell lines and passaged
further. The resulting Wolbachia strain (named wMelPop-
CLA) was then reintroduced into D. melanogaster cured of
wMelPop, where it showed reduced virulence and ability to
induce CI compared to wMelPop (McMeniman et al., 2008).
In Ae. aegypti, wMelPop-CLA induced life-shortening and
CI (McMeniman et al., 2009). Further to this, several species
of Wolbachia from both Drosophila and mosquito species
have been transinfected into different hosts, leading to
different levels of antiviral activity (summarized in Table 2).
For example, in wMel-transinfected Ae. aegypti, WNV was
not inhibited, whereas the presence of the wMelPop strain of
Wolbachia significantly reduced WNV replication (Hussain
et al., 2013). Similarly, wMelPop-CLA, and to a lesser extent
wMel, was able to diminish YFV replication and dissemina-
tion in transinfected Ae. aegypti (van den Hurk et al., 2012).
In the same study it has been shown that wMel can only
inhibit infection and dissemination of CHIKV in transin-
fected Ae. aegypti upon viraemic bloodmeal, but not upon
intrathoracic inoculation (van den Hurk et al., 2012). More
recently, wMel transinfection in Ae. albopictus was found to
prevent CHIKV dissemination to the salivary glands and
thus possibly viral transmission (Blagrove et al., 2013).
Further studies have shown that transinfection of Ae.
aegypti with the D. melanogaster wMelPop-CLA strain of
Wolbachia negatively affects mosquito survival and strongly
inhibits the replication of DENV when compared to
tetracycline-treated (cured of Wolbachia infection) control
or wild-type mosquitoes, irrespective of whether mosqui-
toes were blood fed or whether virus was injected
intrathoracically (Moreira et al., 2009). Wolbachia also
reduced DENV dissemination to the thorax and head of
mosquitoes, and hence possibly transmission (Bian et al.,
2010; Moreira et al., 2009). Ae. aegypti transinfected with
the Ae. albopictus Wolbachia strain wAlbB also showed
increased mosquito longevity upon infection with DENV
and suppressed viral replication (Bian et al., 2010).
It would appear that the Wolbachia-induced virus refrac-
tory phenotype is dependent on the combination of Wol-
bachia strain, virus and host (genetic or other) factors.
Understanding these differences is key to a successful
vector control protocol. Several mechanisms have been
proposed to explain why Wolbachia inhibits arbovirus
transmission effectively in some scenarios but not in
others. These will be discussed below.
Determinants of Wolbachia viral interference in
arthropod hosts
It is not known how Wolbachia endosymbionts confer
antiviral resistance to their hosts, and in order to develop
intervention strategies based on Wolbachia-mediated viral
interference it is crucial to elucidate the underlying me-
chanisms. An important question to address is whether
Wolbachia interferes with viral replication directly or
whether it increases vector resistance to viral infection
by other mechanisms. Furthermore, it is important to
elucidate whether the Wolbachia-mediated effect is cell
autonomous or systemic.
Wolbachia density and competition for host cell
resources
Density. Early studies found a positive correlation between
intracellular endosymbiont density and antiviral effect
conferred (Lu et al., 2012; Osborne et al., 2009, 2012).
Different Wolbachia strains are known to infect vector
species at variable densities and to display different tissue
distributions (Dobson et al., 1999; Dutton & Sinkins, 2004;
Miller & Riegler, 2006). In its native host Ae. albopictus,
wAlbB is found both in reproductive tissues (ovaries,
testes) and somatic tissues (haemolymph, midgut, muscle,
head) (Dobson et al., 1999). In somatic tissues, wAlbB
levels can vary significantly between Ae. albopictus strains
(Dobson et al., 1999). In C. pipiens,Wolbachia densities can
vary up to 100-fold between individual mosquitoes and
also between populations, which could lead to differences
in vector competence (Berticat et al., 2002; Echaubard
et al., 2010; Glaser & Meola, 2010). In heterologous hosts,
however, Wolbachia usually grows to higher densities than
in native hosts, which may explain why antiviral effects are
more often observed in heterologous hosts compared
to native host species (Glaser & Meola, 2010). Examples
of Wolbachia transinfections that resulted in increased
bacterial densities and antiviral resistance compared to
original vector species include infection of Ae. aegypti (Bian
et al., 2010) or Aedes polynesiensis (Bian et al., 2013b) with
wAlbB. An exception is wMelPop, which grows to high
titres in D. melanogaster and leads to a reduced life span of
the host and a reduction in viral replication (Hedges et al.,
2008; Min & Benzer, 1997).
It has been hypothesized that protection is dependent
on whether Wolbachia-harbouring tissues and viral target
cells or tissues co-localize (Bian et al., 2010; Moreira et al.,
2009). Interestingly, in C. pipiens Wolbachia is less abun-
dant in the midgut than in other somatic tissues (Dobson
et al., 1999) and may not be present to limit DENV repli-
cation in midgut epithelial cells (Glaser & Meola, 2010).
Density may also be important if it is simply a case of
competition for space and/or cellular resources. Indeed
there is little evidence of Wolbachia and virus being present
together in the same cell/tissue when either is at a high
density (Frentiu et al., 2010; Moreira et al., 2009).
Autophagy. One mechanism that is thought to control the
density of Wolbachia is autophagy. Infection of C6/36 cells
(an Ae. albopictus-derived cell line) with wAlbB showed
that Wolbachia not only induced the autophagy pathway
Inhibition of arbovirus transmission by Wolbachia
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but also manipulated it in order to ensure survival
(Voronin et al., 2012). This was also true for a naturally
infected D. melanogaster line (wMelPop) (Voronin et al.,
2012). Since both alphaviruses and flaviviruses are thought
to require the autophagy pathway in order to replicate
(Krejbich-Trotot et al., 2011; Lee et al., 2008), this cellular
function may be a site of Wolbachia interference with virus
replication. Further work is clearly required to confirm this
proposal.
Iron metabolism and cholesterol. If the Wolbachia-
mediated antiviral effect is cell autonomous, then one
explanation for reduced virus replication may be com-
petition for resources between Wolbachia, viruses and the
host cell. For example, iron homeostasis has been shown
to be regulated by Wolbachia (Kremer et al., 2009), with
transcriptomic data suggesting that iron-binding proteins,
transferrin and ferritin, were upregulated in the presence
of wMel and wMelPop-CLA in Ae. aegypti (Rance`s et al.,
2012). Data have further indicated that transferrin was
downregulated upon infection with DENV and CHIKV
(Tchankouo-Nguetcheu et al., 2010).
In addition to iron homeostasis, the cholesterol metabol-
ism needs to be tightly regulated to enable viral replication
and bacterial growth. Insect cells are cholesterol auxo-
trophs (Clayton, 1964), and can be depleted of choles-
terol and other lipids by growth in delipidated serum
(Hafer et al., 2009; Silberkang et al., 1983); however, they
will incorporate low levels of cholesterol from serum
(Mitsuhashi et al., 1983). Wolbachia is unable to synthesize
cholesterol de novo and thus its replication is cholesterol-
dependent (Lin & Rikihisa, 2003). Further, inside host cells
individual bacteria are contained within cholesterol-con-
taining Golgi-related vesicles (see also Fig. 2) (Cho et al.,
2011). Cholesterol depletion of host cells by Wolbachia
could also interfere with virus replication. A recent
study has examined the involvement of cholesterol in
Wolbachia-mediated DCV interference in D. melanogaster
(Caragata et al., 2013). It was shown that cholesterol
enrichment of fly diets reversed the Wolbachia-mediated
DCV interference effect and the increase in D. melanogaster
life span in a dose-dependent manner. Importantly, dietary
cholesterol levels did not affect Wolbachia densities in
wMelCS-infected flies and did not affect DCV infection
levels in Wolbachia-free flies (Caragata et al., 2013). For
wMelPop-infected flies there was a significant effect of diet
on Wolbachia density; however, this did not affect
pathogen blocking (Caragata et al., 2013).
Both mosquito-borne alphaviruses and flaviviruses have
been shown to rely on host cell lipids for their uptake,
replication, virion assembly and infectivity. Sindbis virus
(SINV; Togaviridae) and Semliki Forest virus (SFV; Toga-
viridae) are endocytically taken up into host cells, followed
by cholesterol and sphingolipid-dependent fusion of the
viral and host membranes at low pH (Kielian, 1995; Lu
et al., 1999; Smit et al., 1999). Their replication takes
place in replication complexes on intracellular endosome-
derived membranes. In insect cells, virion assembly takes
place in cytoplasmic vesicles that fuse with the plasma
membrane in a cholesterol-dependent manner to release
virus into the medium (Brown & Condreay, 1986). There-
fore, the lipid content of viral particles resembles that of
the producer cells (Hafer et al., 2009). Several studies have
shown that alphaviruses can grow to high titres in insect
cells although their lipid content is generally low (Hafer
et al., 2009; Mitsuhashi et al., 1983; Tsetsarkin et al., 2011).
Cholesterol depletion of C6/36 cells blocked SFV endosome
membrane fusion, replication and exit (Chatterjee et al.,
2000; Marquardt et al., 1993; Phalen & Kielian, 1991). A
significant reduction in the production of infectious SINV
and SFV particles upon delipidation of C6/36 cells has been
reported (Hafer et al., 2009; Lu et al., 1999; Marquardt
et al., 1993; Phalen & Kielian, 1991). It can be assumed that
the lower infectivity of these particles was caused by an
(a) (b)
W V
N
W
V N
Fig. 2. Transmission electron micrographs of Drosophila JW18 cell line infected with Wolbachia. (a) Low magnification image
of a whole cell depicting the distribution of Wolbachia (W) in Drosophila JW18 cells (Serbus et al., 2012), with respect to the
nucleus (N) and vacuoles (V). (b) Higher magnification of the boxed area of the cell in (a) showing a pair of Wolbachia cells in
the same vacuole, presumably at the end of the process of division. Bars, 1 mm (a) and 0.5 mm (b).
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altered lipid composition, which resulted in a loss of
stability and structural fragility of the produced virions.
Interestingly, in addition to cholesterol other lipids seem to
be essential for virion infectivity (Hafer et al., 2009).
Similar to alphaviruses, flavivirus replication relies on a
tight regulation of host cell cholesterol biosynthesis (Carro
& Damonte, 2013; Rothwell et al., 2009). Although DENV
was found to be insensitive to plasma membrane choles-
terol depletion in C6/36 cells (Acosta et al., 2008; Mosso
et al., 2008; Umashankar et al., 2008), extraction of cho-
lesterol from viral envelopes reduced DENV infectivity
for C6/36 cells (Acosta et al., 2009). The differential
dependence on host cell membrane cholesterol content
seen between members of the families Togaviridae and
Flaviviridae may be explained by the fact that the former
viruses bud through the host cell plasma membrane so that
the lipid composition of their envelopes resembles that of
the cell membrane (Hafer et al., 2009; Sousa et al., 2011).
In contrast, the origin of the flavivirus envelope is the
endoplasmic reticulum (Welsch et al., 2009), which con-
tains only a small proportion of the total cell cholesterol
(Lange et al., 1999). Given the crucial role for cholesterol
and other lipids in viral life cycles, it is not surprising that
another flavivirus, WNV, has been shown to modulate host
cell cholesterol levels by upregulating cholesterol biosyn-
thesis and redistributing it to sites of virus replication
(Mackenzie et al., 2007). These cellular modifications are
necessary for WNV replication to take place. In summary,
these early experiments relating to Wolbachia, cholesterol
and antiviral activity are intriguing and warrant further
investigation as it is clear that cholesterol is important both
for virus replication and Wolbachia growth.
Immune signalling in arthropod/Wolbachia
interactions
As Wolbachia is now known to confer resistance to a
broad range of RNA viruses, it could be assumed that the
mechanism(s) behind antiviral activity would also be broad
ranging. Innate immunity consists of a set of anti-microbial
mechanisms largely conserved between insect species and
is the first line of defence against invading microbes,
including viruses (Bartholomay et al., 2010; Christophides
et al., 2002; Lemaitre & Hoffmann, 2007; Waterhouse et al.,
2007). It is therefore plausible to suggest that Wolbachia
may control viral infection by pre-activating the immune
system, also known as immune priming. Much of our
understanding of innate immunity in mosquitoes is in-
fluenced by key findings made in Drosophila studies
(Fragkoudis et al., 2009; Lemaitre & Hoffmann, 2007;
Merkling & van Rij, 2013; Wong et al., 2011).
Toll, Imd and JAK-STAT
Among a number of mechanisms that limit bacterial
infections, three major signalling pathways – Toll, Imd and
JAK-STAT – control innate immunity. The Toll pathway
is initiated upon infection with fungi or Gram-positive
bacteria, leading to transcriptional upregulation of a specific
subset of antimicrobial peptides (AMPs) and several other
immune genes (Lemaitre & Hoffmann, 2007). The Toll
pathway has also been implicated in antiviral immunity. For
example, the pathway is activated by the presence of the
dsRNA virus Drosophila X virus (DXV; Birnaviridae) in
Drosophila (Zambon et al., 2005), and has been implicated
in the control of DENV and WNV in mosquito studies
(Smartt et al., 2009; Xi et al., 2008). Stimulation with Gram-
negative bacteria activates the Imd pathway, and induces
immune genes and Imd-specific AMPs (Lemaitre &
Hoffmann, 2007). Several mutants in the Drosophila Imd
pathway also exhibit higher CrPV titres compared to wild-
type flies (Costa et al., 2009). Studies in An. gambiae suggest
the differential expression of Imd pathway genes in response
to o’nyong’nyong virus (ONNV; Togaviridae); however, it
would only appear to have a minor role in that particular
host–virus interaction (Waldock et al., 2012). A third
pathway known to be involved in both bacterial and viral
infection is the JAK-STAT pathway. DCV, for example,
activates the JAK-STAT pathway in Drosophila resulting
in the upregulation of genes such as vir1 (Dostert et al.,
2005). Studies in Ae. aegypti have demonstrated that DENV
infection is controlled by JAK-STAT signalling (Souza-
Neto et al., 2009; Xi et al., 2008). Indeed, knockdown of key
components of the JAK-STAT pathway resulted in signific-
antly higher DENV viral titres. In the case of alphaviruses,
a number of studies in Drosophila and mosquito cells
suggest that the combination of Imd and/or JAK-STAT
signalling, but not the Toll pathway, has antiviral activities
(Avadhanula et al., 2009; Fragkoudis et al., 2008; Huang
et al., 2013). Importantly, this shows that at least when it
comes to antiviral immune signalling, differences between
virus families, but also within virus families and vectors
(SINV/SFV versus ONNV), exist.
Early studies in Ae. aegypti mosquitoes transinfected
with several different strains of Wolbachia indicated that
immune priming may be involved in antiviral activity.
For example, the transinfection of wMelPop-CLA into Ae.
aegypti resulted in the upregulation of immune genes,
including several involved in the Toll and Imd pathways
(Kambris et al., 2010; Rance`s et al., 2012). Further trans-
criptional analysis of transinfected Ae. aegypti (wAlbB)
showed significant upregulation of several Toll-dependent
genes, in particular the AMP-encoding gene defensin (Bian
et al., 2010). These studies are, however, hampered by the
initial transinfection of heterologous Wolbachia strains.
Naturally infected D. melanogaster, D. simulans, and indeed,
Ae. albopictus do not show this immune priming phenotype,
and in the case of D. simulans and D. melanogaster (and to
some extent Ae. albopictus)Wolbachia still confers resistance
to several RNA viruses (Lu et al., 2012; Osborne et al., 2009;
Rance`s et al., 2012; Teixeira et al., 2008). Significantly,
DENV infection is limited in both D. melanogaster and Ae.
aegypti, which are infected with the strain wMel, to similar
degrees (Rance`s et al., 2012). Therefore, it is unlikely that the
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immune priming seen in Ae. aegypti is key to Wolbachia-
mediated protection, as there is no such priming in
D. melanogaster. It has been shown that there was neither
an induction nor suppression of AMPs in either D. simulans
or Ae. albopictus naturally infected with different Wolbachia
strains (see Tables 1 and 2, respectively) and these insects are
furthermore able to mount a normal response to bacterial
infection (Bourtzis et al., 2000). Immune priming of the
Imd or Toll pathways would also suggest thatWolbachia had
the ability to protect against further bacterial infection;
however, again this is not the case (Rottschaefer & Lazzaro,
2012). A more recent study has utilized the availability
of Drosophila strains that are deficient in key components
of the Imd and Toll pathway to conclude that neither a
functional Toll nor an Imd pathway is required for the
ability of Wolbachia to protect against DENV (Rance`s et al.,
2013).
The Toll pathway has also been shown to be induced by the
production of reactive oxygen species (ROS) in Ae. aegypti
mosquitoes transinfected with the heterologous Wolbachia
strain wAlbB (Pan et al., 2012). The activation of the
pathway in these mosquitoes leads to the production of the
AMPs cecropin and defensin. Targeted reduction of these
two AMPs resulted in an increase of DENV viral titres in
these mosquitoes, leading to speculation that production
of ROS and subsequent Toll activation may lead to
Wolbachia-mediated antiviral activity. However, the cor-
responding experiment was not carried out in Wolbachia-
free lines; therefore, the extent by which this activation leads
to antiviral activity cannot be fully assessed (Pan et al.,
2012). The broad activity ofWolbachia-mediated protection
would argue against immune priming as the main mediator
of antiviral activity, given the different susceptibilities
between viruses to Toll, Imd and JAK-STAT pathways.
A recent study identified the phenoloxidase (PO) cascade
as an important mosquito innate immune response to SFV
(Rodriguez-Andres et al., 2012). Interestingly, Wolbachia
has been shown to increase melanization through the PO
cascade in both homologous and heterologous Wolbachia/
host settings (Thomas et al., 2011). It is likely that the PO
cascade acts to protect against other viruses, and therefore
the interaction with Wolbachia is intriguing and would
merit further investigation.
Taken together, the studies described above suggest that
immune priming is not central to the protection that
Wolbachia confers. However, as transinfection of Wolbachia
strains to heterologous hosts often leads to some level of
immune priming, the additive effect of this cannot be
ignored. It may be that the amount of antiviral protection
present in released mosquitoes is vital to the sustainability of
vector/arbovirus control. Studies suggest that as there is little
or no immune priming present in homologous Wolbachia/
host settings, over time co-evolution would lead to a re-
duction in the immune response. Therefore, it is crucial to
understand to what extent immune priming plays a role in
antiviral activity in transinfected hosts.
Small RNA pathways in arthropod/Wolbachia
interactions
Further to the immune signalling pathways discussed
above, mosquitoes respond to viral infection through the
sequence-specific small RNA breakdown pathways, RNA
interference (RNAi). RNAi is considered to be the most
important antiviral response in insects and is key to the
control of arboviruses in mosquitoes (Blair, 2011). The
exact mechanisms behind antiviral RNAi are beyond the
reach of this review (see Donald et al., 2012 for a recent
review). Nevertheless, as a mechanism that is known to
successfully control a wide variety of arboviruses, it is
important to ascertain if the RNAi response is involved in
mediating the antiviral activity of Wolbachia. Several lines
of evidence, however, suggest that it is not essential. Firstly,
the Ae. albopictus cell line C6/36 does not contain a func-
tional Dicer 2 protein, a key protein in the main antiviral
RNAi response (Brackney et al., 2010; Scott et al., 2010).
Transinfection of these cells with wMel still results in
the inhibition of DENV, suggesting that a functioning
exogenous RNAi response is not necessary for inhibition to
occur (Frentiu et al., 2010). Additionally, Drosophila
mutants defective for several key components of the antiviral
RNAi pathway infected with Wolbachia still show resistance
to WNV, DCV and FHV when compared to control flies
(Glaser & Meola, 2010; Hedges et al., 2012). Taken together
these results indicate that the main antiviral RNAi pathway
is not essential for Wolbachia-mediated viral protection.
In addition to the RNAi pathway, the microRNA (miRNA)
pathway has been implicated in the pathogen-blocking
effect of Wolbachia (Hussain et al., 2011; Osei-Amo et al.,
2012; Zhang et al., 2013). miRNAs are nonprotein-coding
small RNAs that are involved in the regulation of cellular
development, differentiation, apoptosis and immunity
(Asgari, 2013; Donald et al., 2012). Recently, the expression
of miRNAs in Ae. aegypti mosquitoes transinfected with
wMelPop-CLA was studied (Hussain et al., 2011). The
presence of Wolbachia has been shown to alter the ex-
pression of several insect miRNAs. The induction of
one miRNA, aae-miR-2940, by Wolbachia is of particular
interest to this review. aae-miR-2940 has been shown
to downregulate the expression of the metalloprotease
m41 ftsh (Hussain et al., 2011). Inhibition of this miRNA
or silencing of the metalloprotease gene in mosquitoes
reduced Wolbachia density (Hussain et al., 2011). Impor-
tantly, upregulation of aae-miR-2940 by Wolbachia has
been found to inhibit DENV replication. This effect on
DENV is mediated by the downregulation of the Ae. aegypti
DNA (cytosine-5) methyltransferase gene AaDnmt2, a
second target of aae-miR-2940 (Zhang et al., 2013). DNA
cytosine methylation is essential for host defence, genome
stability, gene regulation, organ differentiation and ageing.
Reversely, overexpression of AaDnmt2 leads to a decrease
in Wolbachia density, but an increase in DENV replication.
In DENV-infected, Wolbachia-free mosquitoes, expression
of AaDnmt2 is upregulated. In Wolbachia-free Ae. aegypti,
aae-miR-2940 is, although at low levels, expressed so that
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AaDnmt2 levels are negligible (Zhang et al., 2013). These
findings point towards an important role of aae-miR-2940
in the maintenance of Wolbachia infection in Ae. aegypti
as well as the resistance to DENV in Wolbachia-transin-
fected mosquitoes. Reduction in AaDnmt2 expression in
Wolbachia-infected cells could lead to hypomethylation of
the mosquito genome and thereby regulate expression of
methylation-sensitive host genes (Zhang et al., 2013). In
fact, a recent study has confirmed this idea (Ye et al., 2013).
In particular, expression of Ae. aegypti genes, with mem-
brane functions, appear to be differentially regulated upon
Wolbachia infection (Cho et al., 2011; Ye et al., 2013).
In summary, the studies discussed above suggest that the
RNAi pathway is not essential for Wolbachia-mediated
antiviral activity, but that the miRNA pathway could affect
viral replication either directly, through up or down-
regulation of genes involved in viral replication or antiviral
activity, or indirectly, by altering the density of Wolbachia.
Applications, risks and future directions
Based on its pathogen-blocking effect Wolbachia introduc-
tion into wild mosquito populations has been suggested as a
potential control measure for arboviruses. Previous intro-
ductions of genetically modified (GM) mosquitoes into wild
populations have been met with public concern. However,
Wolbachia is a naturally occurring symbiont of mosquitoes,
and therefore infected vectors are not considered to be
GM. Recent studies have also demonstrated that there is no
antibody production against Wolbachia in human volun-
teers bitten byWolbachia-infected mosquitoes, nor is there a
transfer to the environment (be it mosquito predators,
or soil, leaves, etc.) (Popovici et al., 2010), suggesting
that Wolbachia is a safe alternative to GM mosquitoes.
Nevertheless, public engagement and detailed regulations,
such as those set out by Hoffmann et al. (2011), are key to
public and scientific acceptance of such release experiments.
Release of Wolbachia-infected mosquitoes into wild mos-
quito populations, with the aim of fixation of the infection
frequency (i.e. stable introduction ofWolbachia in previously
non-infected vector populations), requires extensive know-
ledge of local and regional mosquito population densities
and dispersion dynamics (Engelsta¨dter & Telschow, 2009;
Schofield, 2002). Further parameters to consider include
the strength of the Wolbachia-induced CI effect, maternal
inheritance rates and fitness costs or advantages (for example
refractoriness to viral infection) to the vector inferred by
Wolbachia infection (Vavre & Charlat, 2012). Mathematical
modelling approaches are then employed to calculate the
minimum number of Wolbachia-infected mosquitoes to be
released (Hancock & Godfray, 2012; Hoffmann et al., 2011;
Hughes & Britton, 2013; Turelli, 2010; Walker et al., 2011).
A key question is how sustainable a Wolbachia-mediated
approach would be. In order to answer this question, we
firstly need to distinguish between two mechanisms
by which stable introduction of Wolbachia into wild
populations can limit vector competence for pathogen
transmission: (i) Wolbachia-mediated life-shortening of
mosquitoes, which would interfere with viral transmission,
and (ii) Wolbachia-induced vector refractoriness to infec-
tion, which would limit viral replication and transmission
(Vavre & Charlat, 2012). Modelling of the epidemiology of
Wolbachia in host populations has suggested that vector/
Wolbachia associations would be more sustainable in
the field using the former approach as host resistance to
the bacterium is less likely to occur (Read et al., 2009;
Schraiber et al., 2012). However, it has been shown that
mosquitoes carrying life-shortening Wolbachia strains,
such as wMelPop, have to be released in very high numbers
compared to mosquito populations present at the release
site, and that they cannot invade regional mosquito
populations (Hughes & Britton, 2013; McMeniman et al.,
2009; Walker et al., 2011). In contrast to the reduction
of viral transmission due to Wolbachia-induced life-short-
ening, vector refractoriness is expected to diminish over
time as a function of vector/Wolbachia co-adaptation
(Vavre & Charlat, 2012).
As discussed previously, the density of Wolbachia in tran-
sinfected mosquitoes, and indeed in homologous mos-
quito/Wolbachia combinations, is crucial to the Wolbachia-
mediated antiviral activity (Lu et al., 2012; Osborne et al.,
2009, 2012). Therefore, any decrease in Wolbachia density
due to mosquito/Wolbachia co-adaptation may lead to a
significant decrease in antiviral activity. However, it is clear
from studies in D. melanogaster that long-term vector/
Wolbachia/virus associations can lead to continued pro-
tection against viruses. For example, invasion of D.
melanogaster by wMel occurred during the last 80 years
(Riegler et al., 2005), yet wMel still confers protection
against DCV (Teixeira et al., 2008). This is encouraging
and further studies in this model system could be extremely
beneficial to the field.
If, at some point, reintroductions of Wolbachia-infected
mosquitoes are required, then understanding the mech-
anism of CI becomes important. CI will confer an evolu-
tionary advantage to released mosquitoes over the wild
population, which aids the spread and maintenance of
Wolbachia within the wild population. It will, however, also
limit the spread of newly introduced Wolbachia strains into
the same population, as CI will prevent successful mating
of the incoming mosquitoes with individuals of the original
population (see Fig. 1).
Further to CI, the introduction of novel mosquito/
Wolbachia combinations is hindered by the aforemen-
tioned technical difficulties of transinfections. AsWolbachia
transinfection between closely related species is more
successful (Bian et al., 2010; Russell et al., 2009), newly
discovered Wolbachia strains of Ae. bromeliae (a YFV
vector) and Aedes metallicus may be suitable candidates for
introduction into aedine vectors (Osei-Poku et al., 2012).
Transinfection can also result in an evolutionary disadvant-
age within the mosquito, for example reduced fecundity
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or viability. This in turn could affect the spread within a
population. CouplingWolbachia introduction to insecticide
resistance has been suggested in order to counteract these
effects (Hoffmann & Turelli, 2013). Spread of such resis-
tance genes into wild populations requires careful evalu-
ation and is dependent on local mosquito populations and
control strategies.
The impact of introduced Wolbachia on the target
virus may be complex. Modelling indicates that different
Wolbachia strains have varying abilities to reduce trans-
mission frequencies (R0) (Bian et al., 2010; Hoffmann et al.,
2011; McMeniman et al., 2009), and if transmission is only
partially blocked Wolbachia will place the target virus in
a bottleneck, perhaps leading to the evolution of a virus
resistant to Wolbachia-mediated protection. Furthermore,
modelling of the co-evolution of parasites and protecting
symbionts suggests increases in parasite virulence (Jones
et al., 2011). The implication – that exposure to Wolbachia
might result in increased virulence of DENV or CHIKV
– is of obvious concern. There is clearly a need for long-
term studies, perhaps in tissue culture, of the impact of
Wolbachia on virus evolution.
Despite these complications, initial trials with transinfected
mosquitoes are encouraging. Following cage experiments
with Ae. aegypti and wAlbB (Xi et al., 2005), experiments
with wMel and caged Ae. aegypti in semi-field conditions
have shown rapid establishment of infection in the insect
population and inhibition of DENV replication (Walker
et al., 2011). Release experiments into the Australian
environment have achieved spread of wMel into two natural
Ae. aegypti populations within months of release of infected
adult mosquitoes (Hoffmann et al., 2011), with no detec-
table adverse effects on the environment and human health.
Indeed, new field trials are set to begin in Australia (http://
www.eliminatedengue.com/progress).
Wolbachia offers a unique opportunity to potentially
understand and control arbovirus transmission. Indeed,
more recent studies have indicated the use of Wolbachia to
control Plasmodium infections, opening the field further
(Bian et al., 2013a). For virologists, investigating and po-
tentially manipulating the mechanisms underlying the
inhibition of virus transmission by Wolbachia will remain
an interesting and challenging task.
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